13-48362957-G-C
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The NM_000321.3(RB1):c.861G>C(p.Glu287Asp) variant causes a missense, splice region change. The variant was absent in control chromosomes in GnomAD project. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E287G) has been classified as Uncertain significance.
Frequency
Consequence
NM_000321.3 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- hereditary retinoblastomaInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
- retinoblastomaInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- melanomaInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000321.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RB1 | NM_000321.3 | MANE Select | c.861G>C | p.Glu287Asp | missense splice_region | Exon 8 of 27 | NP_000312.2 | ||
| RB1 | NM_001407165.1 | c.861G>C | p.Glu287Asp | missense splice_region | Exon 8 of 27 | NP_001394094.1 | |||
| RB1 | NM_001407166.1 | c.861G>C | p.Glu287Asp | missense splice_region | Exon 8 of 17 | NP_001394095.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RB1 | ENST00000267163.6 | TSL:1 MANE Select | c.861G>C | p.Glu287Asp | missense splice_region | Exon 8 of 27 | ENSP00000267163.4 | ||
| RB1 | ENST00000467505.6 | TSL:1 | n.*229G>C | splice_region non_coding_transcript_exon | Exon 3 of 22 | ENSP00000434702.1 | |||
| RB1 | ENST00000467505.6 | TSL:1 | n.*229G>C | 3_prime_UTR | Exon 3 of 22 | ENSP00000434702.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Retinoblastoma Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Nucleotide substitutions within the consensus splice site are relatively common causes of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of nucleotide changes on RNA splicing suggest that this variant may alter RNA splicing. RT-PCR analysis of patient lymphocyte RNA showed that this variant caused skipping of exon 8 (PMID: 11317357). This variant has been reported in multiple individuals affected with bilateral retinoblastoma (PMID: 11317357, 26539030, 22084214). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glutamic acid with aspartic acid at codon 287 of the RB1 protein (p.Glu287Asp). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and aspartic acid. This variant also falls at the last nucleotide of exon 8 of the RB1 coding sequence, which is part of the consensus splice site for this exon.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at